Sanjay Rathod Selected Research

Folic Acid (Vitamin M)

3/2022

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay Rathod Research Topics

Disease

4	Hypersensitivity (Allergy) 01/2024 - 01/2019
4	Neoplasms (Cancer) 03/2022 - 01/2017
3	Leukemia 01/2024 - 01/2019
2	Anaphylaxis (Anaphylactic Shock) 01/2024 - 01/2020
2	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2017
2	COVID-19 01/2022 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Common Cold 01/2022
1	Infections 01/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Rheumatoid Arthritis 12/2020
1	Communicable Diseases (Infectious Diseases) 06/2020
1	Scrub Typhus (Typhus, Scrub) 04/2020
1	Shock 01/2020

Drug/Important Bio-Agent (IBA)

5	Immunoglobulin G (IgG)IBA 01/2024 - 01/2019
5	AntibodiesIBA 01/2022 - 01/2019
4	Asparaginase (Elspar)FDA Link 01/2024 - 01/2019
4	AntigensIBA 01/2022 - 01/2019
3	Immunoglobulin E (IgE)IBA 01/2024 - 01/2019
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2024 - 10/2019
2	MicellesIBA 03/2022 - 01/2017
2	ProdrugsIBA 03/2022 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2019
1	Immunoglobulin M (IgM)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2022
1	Gemcitabine FDA Link 03/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	pegaspargase (Oncaspar)FDA Link 12/2021
1	Long Noncoding RNAIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	EnzymesIBA 01/2021
1	Neutralizing AntibodiesIBA 12/2020
1	Adalimumab (Humira)FDA Link 12/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020
1	Anti-Infective Agents (Microbicides)IBA 06/2020
1	OligonucleotidesIBA 04/2020
1	DNA (Deoxyribonucleic Acid)IBA 04/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2020
1	anti-IgE antibodiesIBA 01/2019
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2019
1	platelet activating factor receptorIBA 01/2019
1	Immunoglobulin IsotypesIBA 01/2019
1	amsonic acid (DAS)IBA 01/2017
1	DisulfidesIBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2017
2	Immunotherapy 01/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2017